<SEC-DOCUMENT>0001047469-18-000577-index.html : 20180202 <SEC-HEADER>0001047469-18-000577.hdr.sgml : 20180202 <ACCEPTANCE-DATETIME>20180202161457 ACCESSION NUMBER: 0001047469-18-000577 CONFORMED SUBMISSION TYPE: S-3/A PUBLIC DOCUMENT COUNT: 7 FILED AS OF DATE: 20180202 DATE AS OF CHANGE: 20180202 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Syros Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001556263 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 453772460 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-222634 FILM NUMBER: 18570819 BUSINESS ADDRESS: STREET 1: 620 MEMORIAL DRIVE STREET 2: SUITE 300 CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-744-1340 MAIL ADDRESS: STREET 1: 620 MEMORIAL DRIVE STREET 2: SUITE 300 CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: LS22, Inc. DATE OF NAME CHANGE: 20120815 </SEC-HEADER> <DOCUMENT> <TYPE>S-3/A <SEQUENCE>1 <FILENAME>a2234436zs-3a.htm <DESCRIPTION>S-3/A <TEXT> Document 1 - file: a2234436zs-3a.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-4.5 <SEQUENCE>2 <FILENAME>a2234436zex-4_5.htm <DESCRIPTION>EX-4.5 <TEXT> Document 2 - file: a2234436zex-4_5.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5.1 <SEQUENCE>3 <FILENAME>a2234436zex-5_1.htm <DESCRIPTION>EX-5.1 <TEXT> Document 3 - file: a2234436zex-5_1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.1 <SEQUENCE>4 <FILENAME>a2234436zex-23_1.htm <DESCRIPTION>EX-23.1 <TEXT> Document 4 - file: a2234436zex-23_1.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>g33281kqi001.gif <DESCRIPTION>G33281KQI001.GIF <TEXT> Document 5 - file: g33281kqi001.gif
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>6 <FILENAME>g33281kqi002.gif <DESCRIPTION>G33281KQI002.GIF <TEXT> Document 6 - file: g33281kqi002.gif
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>7 <FILENAME>g622400.jpg <DESCRIPTION>G622400.JPG <TEXT> Document 7 - file: g622400.jpg
</DOCUMENT> </SEC-DOCUMENT>